Mitochondrial Bioenergetics and Systemic Regeneration: A Narrative Review and Clinical Case Series of Photobiomodulation-Assisted Stem-Cell Therapy

Background: Photobiomodulation (PBM) is a non-thermal light therapy that enhances mito-chondrial efficiency by targeting cytochrome-c oxidase, thereby increasing ATP production and reducing oxidative stress. Stem cells rely heavily on these mitochondrial metabolic transitions to determine lineage commitment, migration, and reparative function. This article reviews the bioenergetic rationale for combining PBM with stem-cell therapy and explores the potential of this synergistic approach to treat conditions characterised by autonomic dysregulation, chronic inflammation, and impaired cellular repair.
Methods: A narrative critical review was conducted to synthesise literature regarding PBM mechanisms, stem-cell bioenergetics, and marrow-directed phototherapy. Furthermore, a clini-cal case series evaluated the practical application of PBM-assisted autologous stem-cell therapy in three patients. PBM was applied to the proximal tibial bone marrow to stimulate progenitor mobilisation, as well as to autonomic regulatory sites. Outcomes were assessed using validated measures.
Results: Mechanistically, PBM was found to improve mitochondrial oxygen utilisation and sup-port stem-cell viability, paracrine signalling, and systemic mobilisation. Clinically, the com-bined therapy yielded significant improvements across all cases. The vasomotor case demon-strated reduced hot flash frequency and normalised sleep continuity. The fibromyalgia patient reported a reduction in pain intensity (VAS decreased from 8 to 4) and improved functional ca-pacity. The anxiety case showed a reduction in GAD-7 scores from moderate (15) to mild (6), in-dicating improved autonomic stability.
Conclusion: PBM and stem-cell therapy likely operate in synergy through shared mitochondrial, immune-regulatory, and neuroendocrine pathways. PBM acts as a metabolic primer, creating an optimal microenvironment for stem-cell function and systemic repair. While these early find-ings are encouraging for treating complex conditions involving autonomic dysfunction, further controlled trials and standardised dosing protocols are necessary to fully validate this therapeu-tic strategy.